First Line B plus R in Elderly Patients with Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma: A Real- World Experience

被引：0
|
作者：
Kotchetkov, Rouslan [1 ]
Susman, David [2 ]
Gerard, Lauren M. [3 ]
Dimaria, Erica [4 ]
Nay, Derek [5 ]
Prica, Anca [6 ]
机构：
[1] Univ Toronto, Med, Toronto, ON, Canada
[2] Univ Western Ontario, Med, London, ON, Canada
[3] Royal Victoria Hosp, Med Oncol, Barrie, ON, Canada
[4] Royal Victoria Hlth Ctr, Med Oncol, Barrie, ON, Canada
[5] Royal Victoria Hosp, Barrie, ON, Canada
[6] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-144888
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4519
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Effectiveness of radiotherapy for patients with indolent non-Hodgkin's lymphoma
    Hadi, I.
    Schummer, A.
    Eze, C.
    Dreyling, M.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S487 - S488
  • [22] Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Hsiao, Liang-Tsai
    Tien, Hwei-Fang
    Kuo, Ching-Yuan
    Wu, Jin-Hou
    Hou, Hsin-An
    Wang, Ming-Chung
    Liu, Chun-Yu
    Chen, Po-Min
    Chiou, Tzeon-Jye
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (04) : 136 - 144
  • [23] Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma
    Yoong, Y
    Kurtin, PJ
    Allmer, C
    Geyer, S
    Habermann, TM
    Nagorney, M
    Witzig, TE
    LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1235 - 1241
  • [24] Real-World Healthcare Resource Utilization in Patients with Indolent Non-Hodgkin's Lymphoma: Differences between Patients Treated First-Line with Ibrutinib or Bendamustine plus Rituximab
    Irwin, Debra
    Zhang, Lu
    Wilson, Kathleen
    Hoehn, Gerard
    Szabo, Erika
    Tang, Boxiong
    BLOOD, 2018, 132
  • [25] Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
    Kirschbaum, Mark
    Frankel, Paul
    Popplewell, Leslie
    Zain, Jasmine
    Delioukina, Maria
    Pullarkat, Vinod
    Matsuoka, Deron
    Pulone, Bernadette
    Rotter, Arnold J.
    Espinoza-Delgado, Igor
    Nademanee, Auayporn
    Forman, Stephen J.
    Gandara, David
    Newman, Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1198 - 1203
  • [26] Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma
    Cheah, Chan Y.
    Opat, Stephen
    Trotman, Judith
    Marlton, Paula
    INTERNAL MEDICINE JOURNAL, 2019, 49 (09) : 1070 - 1080
  • [27] Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan
    Ogura, Michinori
    Ishizawa, Kenichi
    Maruyama, Dai
    Uike, Naokuni
    Ando, Kiyoshi
    Izutsu, Koji
    Terui, Yasuhito
    Imaizumi, Yoshitaka
    Tsukasaki, Kunihiro
    Suzuki, Kenshi
    Izumi, Tohru
    Usuki, Kensuke
    Kinoshita, Tomohiro
    Taniwaki, Masafumi
    Uoshima, Nobuhiko
    Suzumiya, Junji
    Kurosawa, Mitsutoshi
    Nagai, Hirokazu
    Uchida, Toshiki
    Fukuhara, Noriko
    Choi, Ilseung
    Ohmachi, Ken
    Yamamoto, Go
    Tobinai, Kensei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (04) : 470 - 477
  • [28] Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan
    Michinori Ogura
    Kenichi Ishizawa
    Dai Maruyama
    Naokuni Uike
    Kiyoshi Ando
    Koji Izutsu
    Yasuhito Terui
    Yoshitaka Imaizumi
    Kunihiro Tsukasaki
    Kenshi Suzuki
    Tohru Izumi
    Kensuke Usuki
    Tomohiro Kinoshita
    Masafumi Taniwaki
    Nobuhiko Uoshima
    Junji Suzumiya
    Mitsutoshi Kurosawa
    Hirokazu Nagai
    Toshiki Uchida
    Noriko Fukuhara
    Ilseung Choi
    Ken Ohmachi
    Go Yamamoto
    Kensei Tobinai
    International Journal of Hematology, 2017, 105 : 470 - 477
  • [29] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [30] PHARMACOKINETICS AND TOLERABILITY OF OFATUMUMAB AND BENDAMUSTINE IN PATIENTS WITH INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA
    Forero-Torres, A.
    Chandler, J. C.
    Iyer, S. P.
    Kanate, A. S.
    Quinlan, M.
    Hoever, P.
    Izquierdo, M.
    Duval, V.
    Madan, S.
    HAEMATOLOGICA, 2017, 102 : 469 - 469
12345